|
| Flumatinib Basic information |
Product Name: | Flumatinib | Synonyms: | BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-;4-[(4-Methyl-1-piperazinyl)methyl]-N-[6-methyl-5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-3-pyridinyl]-3-(trifluoromethyl)benzamide;HHGV678;FLUMATINIB (HHGV678);FluMatinib;HHGV-678,Inhibitor,Flumatinib,Bcr-Abl,inhibit,Platelet-derived growth factor receptor,PDGFR,CD117,SCFR,HHGV 678,c-Kit;N-(6-Methyl-5-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)pyridin-3-yl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide | CAS: | 895519-90-1 | MF: | C29H29F3N8O | MW: | 562.59 | EINECS: | | Product Categories: | API | Mol File: | 895519-90-1.mol | |
| Flumatinib Chemical Properties |
density | 1.340±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:100.0(Max Conc. mg/mL);177.75(Max Conc. mM) | form | A solid | pka | 11.84±0.70(Predicted) | color | Off-white to yellow |
| Flumatinib Usage And Synthesis |
| Flumatinib Preparation Products And Raw materials |
|